Regina Thompson

Recommended Articles

• What is Causes Dry Mouth?

  Dry mouth is a very common condition characterized by unusual dryness in the mouth. Along with the inconvenience that it causes, it also affects the taste of food and health of the oral cavity. The mouth becomes unusually dry when the production of saliva is inadequate. This condition is found to be...

• What Are The Side Effects Of Bariatric Surgery?

  Bariatric surgery is also referred to as weight loss surgery. In other cases, it is known as gastric bypass surgery. It is an operation performed mostly on obese people. The main purpose for this type of surgery is to reduce weight.Bariatric surgery involves the removal of certain portions of your...

• Exploring the Benefits of Virtual Reality Rehabilitation in Multiple Sclerosis

  For individuals living with multiple sclerosis (MS), a potentially disabling central nervous system disease, problems with balance and gait are quite common. Such problems include reduced mobility, independence, and quality of life. ...

• What Causes Pleurisy?

  Pleurisy can be caused by a number of things. The causes of pleurisy are described below.InfectionsInfections are most common cause of pleurisy. The most common infection to result in pleurisy is a viral infection. However, any type of organism has the ability and potential to reach the pleural...

• Are IUDs More Effective Than Oral Contraceptives?

  According to experts, intrauterine devices (IUDs) are more effective than the morning after pills in contraception. A recent study has shown that morning after pills have a higher rate of failure, when compared to the coils, a small copper device that is placed in the womb by a trained nurse or...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...